JP2018529770A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018529770A5 JP2018529770A5 JP2018535238A JP2018535238A JP2018529770A5 JP 2018529770 A5 JP2018529770 A5 JP 2018529770A5 JP 2018535238 A JP2018535238 A JP 2018535238A JP 2018535238 A JP2018535238 A JP 2018535238A JP 2018529770 A5 JP2018529770 A5 JP 2018529770A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- amino
- indol
- pyrazol
- propanamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562232629P | 2015-09-25 | 2015-09-25 | |
| US62/232,629 | 2015-09-25 | ||
| PCT/EP2016/072616 WO2017050938A1 (en) | 2015-09-25 | 2016-09-22 | Compounds and methods for inhibiting jak |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018529770A JP2018529770A (ja) | 2018-10-11 |
| JP2018529770A5 true JP2018529770A5 (enExample) | 2020-01-23 |
| JP6767491B2 JP6767491B2 (ja) | 2020-10-14 |
Family
ID=56979589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018535238A Active JP6767491B2 (ja) | 2015-09-25 | 2016-09-22 | Ｊａｋを阻害するための化合物及び方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (5) | US9714236B2 (enExample) |
| EP (2) | EP3353168B1 (enExample) |
| JP (1) | JP6767491B2 (enExample) |
| KR (2) | KR102774784B1 (enExample) |
| CN (4) | CN111606893B (enExample) |
| AR (1) | AR106138A1 (enExample) |
| AU (1) | AU2016328764B2 (enExample) |
| BR (1) | BR112018005833B1 (enExample) |
| CA (1) | CA2995430C (enExample) |
| DK (1) | DK3353168T3 (enExample) |
| ES (1) | ES2956642T3 (enExample) |
| MX (1) | MX375724B (enExample) |
| PT (1) | PT3353168T (enExample) |
| RU (1) | RU2760359C2 (enExample) |
| TW (1) | TWI740843B (enExample) |
| WO (1) | WO2017050938A1 (enExample) |
| ZA (1) | ZA201800782B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102774784B1 (ko) * | 2015-09-25 | 2025-02-27 | 디잘 (지앙수) 파마슈티칼 씨오., 리미티드 | Jak를 억제하기 위한 화합물 및 방법 |
| CN109311858B (zh) | 2016-05-26 | 2021-12-03 | 里科瑞尔姆Ip控股有限责任公司 | Egfr抑制剂化合物 |
| PE20191108A1 (es) | 2017-01-17 | 2019-08-26 | Astrazeneca Ab | Inhibidores selectivos de jak1 |
| KR20190043437A (ko) | 2017-10-18 | 2019-04-26 | 씨제이헬스케어 주식회사 | 단백질 키나제 억제제로서의 헤테로고리 화합물 |
| US11149029B2 (en) * | 2018-07-18 | 2021-10-19 | Astrazeneca Ab | Salts of IJAK inhibitors and methods of using the same |
| EP3854793A4 (en) * | 2018-09-21 | 2022-06-01 | Shanghai Ennovabio Pharmaceuticals Co., Ltd. | AROMATIC HETEROCYCLIC COMPOUND WITH KINASE INHIBITORY ACTIVITY |
| KR102195348B1 (ko) * | 2018-11-15 | 2020-12-24 | 에이치케이이노엔 주식회사 | 단백질 키나제 억제제로서의 신규 화합물 및 이를 포함하는 약제학적 조성물 |
| AU2020258619C1 (en) * | 2019-04-19 | 2026-01-29 | Dizal (Jiangsu) Pharmaceutical Co., Ltd. | JAK1 selective kinase inhibitor |
| CN110627775B (zh) * | 2019-10-24 | 2026-01-30 | 特科罗生物科技(成都)有限公司 | 一种小分子化合物 |
| CN111961037B (zh) * | 2020-09-17 | 2021-09-21 | 嘉兴特科罗生物科技有限公司 | 一种作为jak激酶抑制剂的药物化合物 |
| WO2022111499A1 (zh) | 2020-11-26 | 2022-06-02 | 深圳铂立健医药有限公司 | 一种酰胺化合物、药物组合物及其应用 |
| EP4297873A1 (en) * | 2021-02-26 | 2024-01-03 | Tyra Biosciences, Inc. | Aminopyrimidine compounds and methods of their use |
| US12390451B2 (en) | 2021-03-11 | 2025-08-19 | Janssen Pharmaceutica Nv | Small molecule inhibitor of the JAK family of kinases |
| CN115260128B (zh) * | 2022-09-21 | 2022-12-09 | 苏州凯瑞医药科技有限公司 | 一种新型jak抑制剂关键中间体的制备方法 |
| WO2025230951A1 (en) * | 2024-04-29 | 2025-11-06 | Icahn School Of Medicine At Mount Sinai | Method of treating adenoid cystic carcinoma |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2364340T3 (es) | 2004-03-30 | 2011-08-31 | Vertex Pharmaceuticals Incorporated | Azaindoles útiles como inhibidores de jak y otras proteína quinasas. |
| GB0500492D0 (en) * | 2005-01-11 | 2005-02-16 | Cyclacel Ltd | Compound |
| BRPI0618011A2 (pt) | 2005-10-28 | 2011-08-16 | Astrazeneca Ab | composto ou um sal farmaceuticamente aceitável do mesmo, processo para a preparação do mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, métodos para produzir um efeito anti-proliferativo e um efeito pró-apoptósico em um animal de sangue quente, para tratar doença e para produzir um efeito inibidor de jak em um animal de sangue quente |
| EA200870217A1 (ru) * | 2006-01-30 | 2009-02-27 | Экселиксис, Инк. | 4-арил-2-аминопиримидины или 4-арил-2-аминоалкилпиримидины в качестве модуляторов jak-2 и содержащие их фармацевтические композиции |
| JP5208123B2 (ja) * | 2006-12-08 | 2013-06-12 | アイアールエム・リミテッド・ライアビリティ・カンパニー | タンパク質キナーゼ阻害剤としての化合物および組成物 |
| KR101705158B1 (ko) * | 2009-05-05 | 2017-02-09 | 다나-파버 캔서 인스티튜트 인크. | Ｅｇｆｒ 억제제 및 질환 치료방법 |
| NZ596479A (en) | 2009-05-22 | 2014-01-31 | Incyte Corp | N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors |
| TWI466885B (zh) * | 2009-07-31 | 2015-01-01 | Japan Tobacco Inc | 含氮螺環化合物及其醫藥用途 |
| US20130225615A1 (en) * | 2010-09-01 | 2013-08-29 | Ambit Biosciences Corporation | 2-cycloquinazoline derivatives and methods of use thereof |
| US9198911B2 (en) | 2010-11-02 | 2015-12-01 | The Trustees Of Columbia University In The City Of New York | Methods for treating hair loss disorders |
| AU2011328237A1 (en) * | 2010-11-09 | 2013-05-23 | Cellzome Limited | Pyridine compounds and aza analogues thereof as TYK2 inhibitors |
| CA2818542A1 (en) * | 2010-11-19 | 2012-05-24 | Incyte Corporation | Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors |
| WO2012116247A1 (en) | 2011-02-25 | 2012-08-30 | Synta Pharmaceuticals Corp. | Hsp90 inhibitory compounds in treating jak/stat signaling-mediated cancers |
| US8691807B2 (en) * | 2011-06-20 | 2014-04-08 | Incyte Corporation | Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors |
| DK2830662T3 (da) | 2012-03-29 | 2019-01-02 | Univ Columbia | Fremgangsmåder til behandlng af hårtabsforstyrrelser |
| KR102774784B1 (ko) * | 2015-09-25 | 2025-02-27 | 디잘 (지앙수) 파마슈티칼 씨오., 리미티드 | Jak를 억제하기 위한 화합물 및 방법 |
-
2016
- 2016-09-22 KR KR1020187008186A patent/KR102774784B1/ko active Active
- 2016-09-22 MX MX2018003590A patent/MX375724B/es active IP Right Grant
- 2016-09-22 US US15/272,554 patent/US9714236B2/en active Active
- 2016-09-22 CA CA2995430A patent/CA2995430C/en active Active
- 2016-09-22 PT PT167700319T patent/PT3353168T/pt unknown
- 2016-09-22 DK DK16770031.9T patent/DK3353168T3/da active
- 2016-09-22 WO PCT/EP2016/072616 patent/WO2017050938A1/en not_active Ceased
- 2016-09-22 CN CN202010629290.1A patent/CN111606893B/zh active Active
- 2016-09-22 RU RU2018112993A patent/RU2760359C2/ru active
- 2016-09-22 JP JP2018535238A patent/JP6767491B2/ja active Active
- 2016-09-22 CN CN202010626114.2A patent/CN111848586B/zh active Active
- 2016-09-22 CN CN202010629286.5A patent/CN111646980B/zh active Active
- 2016-09-22 KR KR1020257006096A patent/KR20250035597A/ko active Pending
- 2016-09-22 CN CN201680055491.7A patent/CN108368091B/zh active Active
- 2016-09-22 BR BR112018005833-5A patent/BR112018005833B1/pt active IP Right Grant
- 2016-09-22 EP EP16770031.9A patent/EP3353168B1/en active Active
- 2016-09-22 AU AU2016328764A patent/AU2016328764B2/en active Active
- 2016-09-22 ES ES16770031T patent/ES2956642T3/es active Active
- 2016-09-22 EP EP23150992.8A patent/EP4219482A1/en active Pending
- 2016-09-23 AR ARP160102919A patent/AR106138A1/es active IP Right Grant
- 2016-09-23 TW TW105130891A patent/TWI740843B/zh active
-
2017
- 2017-05-22 US US15/601,324 patent/US10167276B2/en active Active
-
2018
- 2018-02-06 ZA ZA2018/00782A patent/ZA201800782B/en unknown
- 2018-11-20 US US16/196,038 patent/US10654835B2/en active Active
-
2020
- 2020-04-28 US US16/860,169 patent/US11247983B2/en active Active
-
2021
- 2021-12-28 US US17/563,913 patent/US12319670B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022043059A5 (enExample) | ||
| RU2018112993A (ru) | Соединения и способы для ингибирования JAK | |
| JP2020506171A5 (enExample) | ||
| JP2014511892A5 (enExample) | ||
| JP2013056930A5 (enExample) | ||
| JP2013527202A5 (enExample) | ||
| JP2016503786A5 (enExample) | ||
| JP2014139226A5 (enExample) | ||
| JP2014511891A5 (enExample) | ||
| CA2601508A1 (en) | Cyclopropanecarboxamide derivatives | |
| JP2009513703A5 (enExample) | ||
| JP2017527578A5 (enExample) | ||
| JP2009526072A5 (enExample) | ||
| NZ593594A (en) | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | |
| JP2013512899A5 (enExample) | ||
| JP2010504344A5 (enExample) | ||
| JP2008539267A5 (enExample) | ||
| JP2009502743A5 (enExample) | ||
| CN107635975B (zh) | Dgat2抑制剂 | |
| JP2022551973A5 (enExample) | ||
| JP2006504656A5 (enExample) | ||
| NZ703941A (en) | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | |
| JP2010527984A5 (enExample) | ||
| JP2022546414A5 (enExample) | ||
| JP2024520630A5 (enExample) |